mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.006 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.007 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.007 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.007 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.008 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.008 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |